Advances in Ovarian Cancer Screening: Health and Medicine for Women: A Multidisciplinary, Evidence-Based Review of Mid-Life Health Concerns

Early detection is imperative for improving survival from ovarian cancer, the leading cause of death from gynecological cancer in the United States. At the Health and Medicine for Women continuing medical education (CME) conference at Yale in September 2010, Dr. Gil Mor, a researcher in the Departme...

Descripción completa

Detalles Bibliográficos
Autor principal: Ahmad, Sumayya
Formato: Texto
Lenguaje:English
Publicado: YJBM 2011
Materias:
Symposium
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064246/
https://www.ncbi.nlm.nih.gov/pubmed/21451785
Descripción
Sumario:Early detection is imperative for improving survival from ovarian cancer, the leading cause of death from gynecological cancer in the United States. At the Health and Medicine for Women continuing medical education (CME) conference at Yale in September 2010, Dr. Gil Mor, a researcher in the Department of OB/GYN at Yale, presented recent advances on the pathophysiology of ovarian cancer. These advances, and particularly our growing understanding of cancer stem cells, may help overcome the limitations of current ovarian cancer detection and treatment methods.

Ejemplares similares